Effect of Biofeedback and Functional Electrical Stimulation in Children

December 18, 2024 updated by: Alaa Eldin Taha Ramadan, Cairo University

Combined Effect of Biofeedback and Functional Electrical Stimulation on Upper Limb Functions in Children With Hemiplegia

40 children with hemiplegia cerebral palsy from both sex will be recruited from outpatient clinic of abo resh hospital ,their age ranged from 5-10 years

Study Overview

Status

Recruiting

Conditions

Detailed Description

40 children with hemiplegia cerebral palsy from both sex will be recruited ,their age ranged from 5-10 years, treatment includes functional electrical nerve stimulation and biofeedback to assess their combined effect on upper limb function

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Giza, Egypt, 12613
        • Recruiting
        • Cairo university

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Their age will range from 5 to 10 years.
  • Spasticity grade range from 1+ to 2, according to Modified Ashworth Scale (MAS) (Bohannon and Smith, 2011).
  • Their UL ability function will be at level II according to Manual Ability Classification System (MACS) (Penta et al., 2001).
  • They will be able to follow instructions.

Exclusion Criteria:

  • Loss of sensation
  • The presence of visual or auditory impairments.
  • Musculoskeletal problems or fixed deformities in the upper extremities.
  • Seizures.
  • Surgical interference in upper limbs.
  • Botulinum toxin injections in the last 6 months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Group A

Physical therapy program The exercise session for one hour for each child , conducted 3times/ week for 3 successive months.

  1. Flexibility exercises for shorted muscles and spastic muscles.
  2. Strengthening training focusing on the trunk lower limb and upper limb muscles for weak muscles.
  3. Postural control exercise in different positions and different surfaces
  4. General endurance training
  5. Exercises to facilitate hand function
  6. Exercises included, grasping a cube, transferring cube, removing and placing pegs, releasing cube and placing cubes. Strengthening exercises of the intrinsic muscles of the hand
Flexibility exercises for shorted muscles and spastic muscles, Strengthening training focusing on the trunk lower limb and upper limb muscles for weak muscles, Postural control exercise in different positions and different surfaces, General endurance training, Exercises to facilitate hand function, Exercises included, grasping a cube, transferring cube, removing and placing pegs, releasing cube and placing cubes. Strengthening exercises of the intrinsic muscles of the hand
Experimental: Group B
The exercise session for one hour for each child same as group A, conducted 3times/ week for 3 successive months plus the combined biofeedback therapy and FES at anti spastic muscles (shoulders flexors, elbow and wrist extensors
Flexibility exercises for shorted muscles and spastic muscles, Strengthening training focusing on the trunk lower limb and upper limb muscles for weak muscles, Postural control exercise in different positions and different surfaces, General endurance training, Exercises to facilitate hand function, Exercises included, grasping a cube, transferring cube, removing and placing pegs, releasing cube and placing cubes. Strengthening exercises of the intrinsic muscles of the hand
biofeedback therapy and FES at anti spastic muscles(shoulders flexors, elbow and wrist extensors) while doing specific exercises (including basic reaching, grasping, carrying, release

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hand function in children with CP
Time Frame: pre intervention and re assessed after 3 months of treatment
hand function in children with CP will be assessed by The Quality of Upper Extremity Skills Test
pre intervention and re assessed after 3 months of treatment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of motion
Time Frame: pre intervention and re assessed after 3 months of treatment
Range of motion will be assessed using Electronic goniometer
pre intervention and re assessed after 3 months of treatment
muscle grip strength
Time Frame: pre intervention and re assessed after 3 months of treatment
muscle grip strength will be assessed using Hand held dynamometer
pre intervention and re assessed after 3 months of treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Khaled A Mamdouh, PHD, Professor of physical therapy
  • Study Director: Eman I Alhadedy, PHD, Professor of physical therapy
  • Study Director: Amira I Fathi, Lecturer of physical therapy

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2024

Primary Completion (Estimated)

March 1, 2025

Study Completion (Estimated)

March 1, 2025

Study Registration Dates

First Submitted

December 8, 2024

First Submitted That Met QC Criteria

December 8, 2024

First Posted (Actual)

December 11, 2024

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 18, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 012/005003

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemiplegia

Clinical Trials on Physical therapy program

Subscribe